Quality prescribing for respiratory illness 2024 to 2027 - draft guidance: consultation
We are consulting on this draft guide which aims to optimise treatment outcomes in the management of respiratory illness. Produced by Scottish Government, NHS Scotland and Experts by Experience, it builds on the 2018 to 2021 strategy. It promotes person-centred care, the 7-Steps process for medicine reviews and shared decision-making.
Acknowledgements
Chairpersons
David Anderson , Respiratory Consultant, NHS Greater Glasgow and Clyde
Tom Fardon, Respiratory Consultant, NHS Tayside
Deputy Chairperson
Alpana Mair, Head of Effective Prescribing and Therapeutics Division, Scottish Government
Lead Authors
Lesley Rose Lead Pharmacist - Respiratory, Effective Prescribing and Therapeutics Division, Scottish Government
Emily Kennedy, Climate Change and Sustainability Lead Pharmacist, Effective Prescribing and Therapeutics Division, Scottish Government
Working Group Members
Allan White, Respiratory Advisor, Chest Heart and Stroke Scotland
Alpana Mair, Head of Effective Prescribing and Therapeutics Division, Scottish Government
Andrew Jack, Patient expert with lived experience
Ann Wales, Programme Lead, Knowledge and Decision Support, Digital Health and Care Innovation Centre
Beth Crozier, Senior Policy Officer, Effective Prescribing and Therapeutics Division, Scottish Government
Bryony Murray, Senior Policy Officer, Respiratory and Diabetes, Scottish Government
Caitlin Frickleton, Policy Manager - Diabetes and Respiratory, Scottish Government
Catriona Wheelan, Pharmacist - Secondary Care, NHS Highland
David Anderson, Respiratory Consultant, NHS Greater Glasgow and Clyde
Elizabeth Daniel, Prescribing Respiratory Physiotherapist, NHS Lothian
Emily Kennedy, Lead Pharmacist, Primary Care, NHS Dumfries and Galloway
Euan Reid Lead Pharmacist, Primary Care, NHS Dumfries and Galloway
Lead Pharmacist - Primary Care, NHS Forth Valley
Jacqueline Davidson Respiratory Specialist Nurse, Secondary Care, NHS Lanarkshire
Joseph Carter Head of Devolved Nations, Asthma and Lung UK
Julie Lennon GP Practice Nurse (ANP), NHS Highland and NES Nurse Adviser
Iain Wilson GP Clinical Lead, Effective Prescribing and Therapeutics Division, Scottish Government
Katie Johnston, Lead Respiratory Pharmacist, Primary Care, NHS Lothian
Katrina McCormick, Professional Engagement, Chest Heart and Stroke Scotland
Kris McLaughlin, GP, NHS Grampian
Laura Groom, Prescribing Respiratory Physiotherapist, NHS Lothian
Laura Wilson, Policy and Practice Lead, Royal Pharmaceutical Society
Lesley Rose, Lead Pharmacist - Respiratory, Effective Prescribing and Therapeutics Division, Scottish Government
Linda Mcleod, Patient expert with lived experience
Luke Daines, GP, NHS Lothian and Senior Research / Clinical Teaching Fellow, University of Edinburgh
Lynda Bryceland, Respiratory Specialist Nurse, NHS Ayrshire and Arran
Nadia Hyder, Skinner Senior Policy Officer, Effective Prescribing and Therapeutics Division, Scottish Government
Paul Paxton, Senior Information Analyst, Public Health Scotland
Richard Ousten, Patient expert with lived experience
Stuart Law, Head of Policy and Research, Effective Prescribing and Therapeutics Division, Scottish Government
Stuart McTaggart, Principal Pharmacist, Public Health Scotland
Susannah Lindey, Patient expert with lived experience
Tom Fardon, Respiratory Consultant, NHS Tayside
With acknowledgements to:
Graeme Bryson, Director of Pharmacy, NHS Dumfries and Galloway
Janey Lennon, Prescribing Support Pharmacist, NHS Greater Glasgow and Clyde
Joanna Hutchison, Lead Respiratory Pharmacist, NHS Lothian
Karen Vint, Prescribing Support Pharmacist, NHS Greater Glasgow and Clyde
Ann McMurray, Asthma Nurse Specialist, Royal Hospital for Children and Young People, NHS Lothian
Contact
Email: EPandT@gov.scot
There is a problem
Thanks for your feedback